History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs

被引:14
|
作者
Schuster, Charles R. [1 ]
机构
[1] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Subst Abuse Res Div, Detroit, MI 48207 USA
关键词
formulations; college on problems of drug dependence; abuse liability; exempt preparations; history; regulation; international drug treaties;
D O I
10.1016/j.drugalcdep.2006.01.006
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This article is part of a supplemental issue of the journal devoted entirely to papers on how abuse liability of medications is affected by their formulation for medical use. This article reviews the history of abuse and addiction to medications in the United States and the legislation designed to control these problems. The provisions in legislation related specifically to formulations of medications designed to decrease their abuse potential will be noted. In addition, the role of the College on Problems of Drug Dependence (CPDD) as an organization initially founded to develop analgesic medications with less abuse potential than morphine is briefly reviewed. Examples of current approaches to the development of formulations of medications to decrease their abuse potential discussed in detail in the articles to follow are outlined. Finally, the use of behavioral economic analyses to better delineate the relative abuse potential of new medication formulations is discussed. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S8 / S14
页数:7
相关论文
共 50 条
  • [1] Poison center efforts to decrease prescription drug abuse
    Chambers-Emerson, Joann
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 635 - 635
  • [2] Drugs on Saturday to combat "Prescription drug abuse"
    Sivagnanam, G.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 217 - U141
  • [3] Prescription Drug Abuse in Canada and the Diversion of Prescription Drugs into the Illicit Drug Market
    Emma Haydon
    Jürgen Rehm
    Benedikt Fischer
    Neerav Monga
    Edward Adlaf
    Canadian Journal of Public Health, 2005, 96 : 459 - 461
  • [4] Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market
    Haydon, E
    Rehm, J
    Fischer, B
    Monga, N
    Adlaf, E
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2005, 96 (06): : 459 - 461
  • [5] The prescription of psychotropic drugs: Use, misuse and abuse
    Zarifian, E
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1998, 182 (07): : 1439 - 1447
  • [6] Analytical surveillance of emerging drugs of abuse and drug formulations
    Thomas, Brian F.
    Pollard, Gerald T.
    Grabenauer, Megan
    LIFE SCIENCES, 2013, 92 (8-9) : 512 - 519
  • [7] Prescription Drug Abuse: A Comparison of Prescriber and Pharmacist Perspectives
    Hagemeier, Nicholas E.
    Gray, Jeffrey A.
    Pack, Robert P.
    SUBSTANCE USE & MISUSE, 2013, 48 (09) : 761 - 768
  • [8] IMPACT OF POLYDRUG USE ON PRESCRIPTION DRUG ABUSE
    Parikh, N. S.
    Nayak, R.
    VALUE IN HEALTH, 2013, 16 (03) : A57 - A57
  • [9] A review on advanced formulations strategies to prevent prescription drug abuse and their impact
    Bhargav Chandegra
    Jigar Raval
    Prajesh Prajapati
    Discover Medicine, 1 (1):
  • [10] CURRENT CONDITIONS AND TREATMENT OF PRESCRIPTION DRUG ABUSE IN JAPAN
    Nakano, H.
    ALCOHOL AND ALCOHOLISM, 2014, 49